Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

Literature DB >> 900925

Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

W E Sanders, E C Hartwig, N J Schneider, R Cacciatore, H Valdez.

Abstract

Of 21 antimicrobial agents tested in vitro, amikacin was the most predictably active against clinical isolates belonging to the Mycobacterium fortuitum complex; however, only 50% of strains studied were susceptible to clinically attainable concentrations of the drug.

Entities: Chemical Species

Mesh：

Substances：

Year: 1977 PMID： 900925 PMCID： PMC429903 DOI： 10.1128/AAC.12.2.295

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

10 in total

1. M. fortuitum: its identification, incidence, and significance in Florida.

Authors: E C HARTWIG; R CACCIATORE; F P DUNBAR
Journal: Am Rev Respir Dis Date: 1962-01

2. Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test.

Authors: F P DUNBAR; R DAVIS; M B JEFFERIES
Journal: Am Rev Tuberc Date: 1958-02

3. Atypical mycobacteria in a tuberculosis hospital.

Authors: G L Gale
Journal: Can Med Assoc J Date: 1976-04-03 Impact factor: 8.262

4. The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.

Authors: R B Dreisin; C Scoggin; P T Davidson
Journal: Tubercle Date: 1976-03

5. Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria.

Authors: G P Kubica
Journal: Am Rev Respir Dis Date: 1973-01

6. Mycobacteria in soil and their relation to disease-associated strains.

Authors: E Wolinsky; T K Rynearson
Journal: Am Rev Respir Dis Date: 1968-06

7. A study on pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. 18. A report of the Veterans Administration-Armed Forces Cooperative Study.

Authors: G L Hobby; W B Redmond; E H Runyon; W B Schaefer; L G Wayne; R H Wichelhausen
Journal: Am Rev Respir Dis Date: 1967-06

8. Mycobacterium fortuitum--a human pathogen.

Authors: W L Hand; J P Sanford
Journal: Ann Intern Med Date: 1970-12 Impact factor: 25.391

9. Ten mycobacterial pathogens.

Authors: E H Runyon
Journal: Tubercle Date: 1974-09

10. Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.

Authors: W E Sanders; R Cacciatore; H Valdez; I Pejovic; F P Dunbar
Journal: J Infect Dis Date: 1971-12 Impact factor: 5.226

10 in total

12 in total

10. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Authors: R J Wallace; J R Dalovisio; G A Pankey
Journal: Antimicrob Agents Chemother Date: 1979-11 Impact factor: 5.191

Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

1. M. fortuitum: its identification, incidence, and significance in Florida.

2. Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test.

3. Atypical mycobacteria in a tuberculosis hospital.

4. The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.

5. Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria.

6. Mycobacteria in soil and their relation to disease-associated strains.

7. A study on pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. 18. A report of the Veterans Administration-Armed Forces Cooperative Study.

8. Mycobacterium fortuitum--a human pathogen.

9. Ten mycobacterial pathogens.

10. Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.

1. Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.

2. Postoperative osteomyelitis due to Mycobacterium fortuitum. A case report.

3. Prosthetic valve endocarditis due to Mycobacterium fortuitum.

4. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.

5. In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.

6. Mycobacterial isolations in young adults with cystic fibrosis.

7. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

8. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.

9. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.

10. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.